64 Management of EGFR tyrosine kinase inhibitor associated skin toxicity: a single centre experience. (January 2016) - Thomas, L.; Hadaki, M.; Sevitt, T.; Shah, R.; Burcombe, R.; Hall, J.; Taylor, H.; Beesley, S.; Cominos, M.